By Dean Seal
Immunocore Holdings hired a non-executive director on its board as the company's chief financial officer.
The U.K. biotechnology company Thursday said Travis Coy has been appointed CFO and head of corporate development.
He succeeds Brian Di Donato, who told the company over the summer he would step down by the end of the year to take a role as chief executive at an early-stage biotech firm based in San Diego.
Coy was previously the head of transactions and mergers and acquisitions at Eli Lilly. He has served as non-executive director of Immunocore since September 2019.
Write to Dean Seal at dean.seal@wsj.com
(END) Dow Jones Newswires
January 02, 2025 07:34 ET (12:34 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.